Compared with nontumor tissues, FAM134B is upregulated in hepatocellular carcinoma (HCC), as well as being associated with tumor proliferation and metastasis via the AKT and GSK3-β signaling pathways. Here, RETREG1 is linked to hepatocellular carcinoma.